Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, nominal value (euro)0.12 per share
-
Shares outstanding
-
67,811,197
-
Total 13F shares
-
3,514,581
-
Share change
-
-89,925
-
Total reported value
-
$17,683,000
-
Price per share
-
$5.03
-
Number of holders
-
31
-
Value change
-
-$293,543
-
Number of buys
-
19
-
Number of sells
-
13
Institutional Holders of InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) as of Q4 2020
As of 31 Dec 2020,
InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,514,581 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, MORGAN STANLEY, ORBIMED ADVISORS LLC, FNY Investment Advisers, LLC, Bank Julius Baer & Co. Ltd, Zurich, Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, Verition Fund Management LLC, Birchview Capital, LP, and SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.